CFDA: the end of the pilot work of online drug retail on the third-party Internet platform

Source: China Pharmaceutical News July 29, 2016, the State Food and drug administration notified the food and Drug Administration of Hebei Province, Shanghai city and Guangdong Province respectively to end the pilot work of online drug retail on the third-party Internet platform It is understood that in 2013, the General Administration of food and Drug Administration of the three provinces and cities successively approved the "95095" platform of Hebei Huiyan Pharmaceutical Technology Co., Ltd., the "800" platform of Guangzhou 800 Party Information Technology Co., Ltd and the "1" platform of new sea e-commerce (Shanghai) Co., Ltd The "store" platform will carry out the pilot work of online drug retail on the third-party Internet platform for a period of one year During the pilot process, problems such as unclear responsibilities of the third-party platform and entity drugstores, difficulty in effective supervision over the sale of prescription drugs and drug quality and safety were exposed, which was not conducive to the protection of consumer interests and drug safety Therefore, it was decided to end the pilot work of online retail of drugs on the third-party Internet platform The General Administration said it would end the third party peace The pilot work of online retail of Taiwan drugs will not affect the enterprises that have already obtained the qualification certificate of Internet drug trading service to continue to carry out the drug trading service business of enterprises and medical institutions in accordance with the Interim Provisions on the examination and approval of Internet drug trading service and other provisions; the entity drugstores that have obtained the qualification certificate of Internet drug trading service can continue to directly through the Internet To sell drugs to consumers The General Administration stressed that all drug retail enterprises, whether trading online or in stores, must strictly implement the regulations of selling prescription drugs by doctors' prescriptions